Purpose: To determine the retinal and choroidal vessel density in the macular area with swept-source optical coherence tomography (OCT) angiography (SS-OCTA) in patients affected by retinitis pigmentosa (RP), to compare their data with those on healthy subjects, and to study a possible morphofunctional correlation by microperimetry (MP-1). Methods: A total of 40 eyes of 40 patients affected by RP and 24 eyes of 24 healthy subjects were included in the study. Manually moving down the segmentation line of the SS-OCTA, we have evaluated the vessel density for the superficial retinal plexus, deep retinal plexus, choriocapillaris, and three levels of the choroid. Results: Linear regression analyses were performed of the retinal structure and function. No significant correlation was detected in any case (R2 = 0, p > 0.05). A comparison between RP and healthy controls revealed a significant reduction in SS-OCTA mean capillary density in the RP group (p = 0.0011). This relationship was consistent across vascular layers (p = 0.2413). A significant association between the capillary density of the various vascular complexes was detected within individual eyes (p < 0.0001). Conclusions: This study represents the first comparing MP-1 and SS-OCTA data in the largest cohort of patients. RP patients showed a reduction in both the retinal and the choroidal vascular network in the macular area compared to healthy subjects.

1.
Verbakel
SK
,
van Huet
RA
,
Boon
CJ
,
den Hollander
AI
,
Collin
RW
,
Klaver
CC
, et al.
Non-syndromic retinitis pigmentosa
.
Prog Retin Eye Res
.
2018
Sep
;
66
:
157
86
.
[PubMed]
1350-9462
2.
Na
KH
,
Kim
HJ
,
Kim
KH
,
Han
S
,
Kim
P
,
Hann
HJ
, et al.
Prevalence, age at diagnosis, mortality and cause of death in retinitis pigmentosa in Korea - a nationwide population-based study
.
Am J Ophthalmol
.
2017
Apr
;
176
:
157
65
.
[PubMed]
0002-9394
3.
Daiger
,
S.P.
,
Sullivan
,
L.S.
,
Bowne
,
S.J.
RetNet, the Retinal Information Network.
2016
.
4.
Padnick-Silver
L
,
Kang Derwent
JJ
,
Giuliano
E
,
Narfström
K
,
Linsenmeier
RA
.
Retinal oxygenation and oxygen metabolism in Abyssinian cats with a hereditary retinal degeneration
.
Invest Ophthalmol Vis Sci
.
2006
Aug
;
47
(
8
):
3683
9
.
[PubMed]
0146-0404
5.
Penn
JS
,
Li
S
,
Naash
MI
.
Ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
2000
Nov
;
41
(
12
):
4007
13
.
[PubMed]
0146-0404
6.
Yu
DY
,
Cringle
SJ
.
Retinal degeneration and local oxygen metabolism
.
Exp Eye Res
.
2005
Jun
;
80
(
6
):
745
51
.
[PubMed]
0014-4835
7.
Narayan
DS
,
Wood
JP
,
Chidlow
G
,
Casson
RJ
.
A review of the mechanisms of cone degeneration in retinitis pigmentosa
.
Acta Ophthalmol
.
2016
Dec
;
94
(
8
):
748
54
.
[PubMed]
1755-375X
8.
Heckenlively
J
.
The frequency of posterior subcapsular cataract in the hereditary retinal degenerations
.
Am J Ophthalmol
.
1982
Jun
;
93
(
6
):
733
8
.
[PubMed]
0002-9394
9.
Pruett
RC
.
Retinitis pigmentosa: clinical observations and correlations
.
Trans Am Ophthalmol Soc
.
1983
;
81
:
693
735
.
[PubMed]
0065-9533
10.
Strong
S
,
Liew
G
,
Michaelides
M
.
Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention
.
Br J Ophthalmol
.
2017
Jan
;
101
(
1
):
31
7
.
[PubMed]
0007-1161
11.
Liew
G
,
Strong
S
,
Bradley
P
,
Severn
P
,
Moore
AT
,
Webster
AR
, et al.
Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa
.
Br J Ophthalmol
.
2019
Aug
;
103
(
8
):
1163
6
.
[PubMed]
0007-1161
12.
Chebil
A
,
Touati
S
,
Maamouri
R
,
Kort
F
,
El Matri
L
.
Spectral Domain optical coherence tomography findings in patients with retinitis pigmentosa
.
Tunis Med
.
2016
Apr
;
94
(
4
):
265
71
.
[PubMed]
0041-4131
13.
Fujiwara
K
,
Ikeda
Y
,
Murakami
Y
,
Nakatake
S
,
Tachibana
T
,
Yoshida
N
, et al.
Association between aqueous flare and epiretinal membrane in retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
2016
Aug
;
57
(
10
):
4282
6
.
[PubMed]
0146-0404
14.
Hagiwara
A
,
Yamamoto
S
,
Ogata
K
,
Sugawara
T
,
Hiramatsu
A
,
Shibata
M
, et al.
Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery
.
Acta Ophthalmol
.
2011
Mar
;
89
(
2
):
e122
5
.
[PubMed]
1755-375X
15.
Testa
F
,
Rossi
S
,
Colucci
R
,
Gallo
B
,
Di Iorio
V
,
della Corte
M
, et al.
Macular abnormalities in Italian patients with retinitis pigmentosa
.
Br J Ophthalmol
.
2014
Jul
;
98
(
7
):
946
50
.
[PubMed]
0007-1161
16.
Triolo
G
,
Pierro
L
,
Parodi
MB
,
De Benedetto
U
,
Gagliardi
M
,
Manitto
MP
, et al.
Spectral domain optical coherence tomography findings in patients with retinitis pigmentosa
.
Ophthalmic Res
.
2013
;
50
(
3
):
160
4
.
[PubMed]
0030-3747
17.
Mitamura
Y
,
Mitamura-Aizawa
S
,
Nagasawa
T
,
Katome
T
,
Eguchi
H
,
Naito
T
.
Diagnostic imaging in patients with retinitis pigmentosa
.
J Med Invest
.
2012
;
59
(
1-2
):
1
11
.
[PubMed]
1343-1420
18.
Sujirakul
T
,
Lin
MK
,
Duong
J
,
Wei
Y
,
Lopez-Pintado
S
,
Tsang
SH
.
Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa
.
Am J Ophthalmol
.
2015
Oct
;
160
(
4
):
786
98.e4
.
[PubMed]
0002-9394
19.
Sujirakul
T
,
Davis
R
,
Erol
D
,
Zhang
L
,
Schillizzi
G
,
Royo-Dujardin
L
, et al.
Bilateral Concordance of the Fundus Hyperautofluorescent Ring in Typical Retinitis Pigmentosa Patients
.
Ophthalmic Genet
.
2015
Jun
;
36
(
2
):
113
22
.
[PubMed]
1381-6810
20.
Cabral
T
,
Sengillo
JD
,
Duong
JK
,
Justus
S
,
Boudreault
K
,
Schuerch
K
, et al.
Retrospective Analysis of Structural Disease Progression in Retinitis Pigmentosa Utilizing Multimodal Imaging
.
Sci Rep
.
2017
Sep
;
7
(
1
):
10347
.
[PubMed]
2045-2322
21.
Yoon
CK
,
Yu
HG
.
Ganglion cell-inner plexiform layer and retinal nerve fibre layer changes within the macula in retinitis pigmentosa: a spectral domain optical coherence tomography study. Acta Ophthalmol. 2018 Mar;96(2):e180-e188. Nicolo’ M, Rosa R, Musetti D, Musolino M, Saccheggiani M, Traverso CE. Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography
.
Invest Ophthalmol Vis Sci
.
2017
;
58
:
2002
10
.0146-0404
22.
Nicolò M, Rosa R, Musetti D, Musolino M, Saccheggiani M, Traverso CE. Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58(4):2002–10.
23.
Inooka
D
,
Ueno
S
,
Kominami
T
,
Sayo
A
,
Okado
S
,
Ito
Y
, et al.
Quantification of Macular Microvascular Changes in Patients With Retinitis Pigmentosa Using Optical Coherence Tomography Angiography
.
Invest Ophthalmol Vis Sci
.
2018
Jan
;
59
(
1
):
433
8
.
[PubMed]
0146-0404
24.
Rezaei
KA
,
Zhang
Q
,
Chen
CL
,
Chao
J
,
Wang
RK
.
Retinal and choroidal vascular features in patients with retinitis pigmentosa imaged by OCT based microangiography
.
Graefes Arch Clin Exp Ophthalmol
.
2017
Jul
;
255
(
7
):
1287
95
.
[PubMed]
0721-832X
25.
Battaglia Parodi
M
,
Cicinelli
MV
,
Rabiolo
A
,
Pierro
L
,
Gagliardi
M
,
Bolognesi
G
, et al.
Vessel density analysis in patients with retinitis pigmentosa by means of optical coherence tomography angiography
.
Br J Ophthalmol
.
2017
Apr
;
101
(
4
):
428
32
.
[PubMed]
0007-1161
26.
Alnawaiseh
M
,
Schubert
F
,
Heiduschka
P
,
Eter
N
.
Optical coherence tomography angiography in patients with retinitis pigmentosa
.
Retina
.
2017
Oct
;
1
.
[PubMed]
0275-004X
27.
Mastropasqua
R
,
Borrelli
E
,
Agnifili
L
,
Toto
L
,
Di Antonio
L
,
Senatore
A
, et al.
Radial Peripapillary Capillary Network in Patients with Retinitis Pigmentosa: An Optical Coherence Tomography Angiography Study
.
Front Neurol
.
2017
Oct
;
8
:
572
.
[PubMed]
1664-2295
28.
Jauregui
R
,
Park
KS
,
Duong
JK
,
Mahajan
VB
,
Tsang
SH
.
Quantitative progression of retinitis pigmentosa by optical coherence tomography angiography
.
Sci Rep
.
2018
Sep
;
8
(
1
):
13130
.
[PubMed]
2045-2322
29.
Murakami
Y
,
Funatsu
J
,
Nakatake
S
,
Fujiwara
K
,
Tachibana
T
,
Koyanagi
Y
, et al.
Relations Among Foveal Blood Flow, Retinal-Choroidal Structure, and Visual Function in Retinitis Pigmentosa
.
Invest Ophthalmol Vis Sci
.
2018
Feb
;
59
(
2
):
1134
43
.
[PubMed]
0146-0404
30.
Battu
R
,
Khanna
A
,
Hegde
B
,
Berendschot
TT
,
Grover
S
,
Schouten
JS
.
Correlation of structure and function of the macula in patients with retinitis pigmentosa
.
Eye (Lond)
.
2015
Jul
;
29
(
7
):
895
901
.
[PubMed]
0950-222X
31.
Lupo
S
,
Grenga
PL
,
Vingolo
EM
.
Fourier-domain optical coherence tomography and microperimetry findings in retinitis pigmentosa
.
Am J Ophthalmol
.
2011
Jan
;
151
(
1
):
106
11
.
[PubMed]
0002-9394
32.
Asahina
Y
,
Kitano
M
,
Hashimoto
Y
,
Yanagisawa
M
,
Murata
H
,
Inoue
T
, et al.
The structure-function relationship measured with optical coherence tomography and a microperimeter with auto-tracking: the MP-3, in patients with retinitis pigmentosa
.
Sci Rep
.
2017
Nov
;
7
(
1
):
15766
.
[PubMed]
2045-2322
33.
Sayman Muslubas
I
,
Karacorlu
M
,
Arf
S
,
Hocaoglu
M
,
Ersoz
MG
.
Features of the macula and central visual field and fixation pattern in patients with retinitis pigmentosa
.
Retina
.
2018
Feb
;
38
(
2
):
424
31
.
[PubMed]
0275-004X
34.
Ayton
LN
,
Guymer
RH
,
Luu
CD
.
Choroidal thickness profiles in retinitis pigmentosa
.
Clin Exp Ophthalmol
.
2013
May-Jun
;
41
(
4
):
396
403
.
[PubMed]
1442-6404
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.